Zions Bancorporation (ZION) Receives Consensus Rating of “Buy” from Brokerages

Zions Bancorporation (NASDAQ:ZION) has earned an average recommendation of “Buy” from the twenty-two brokerages that are covering the company, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, eight have issued a hold recommendation and thirteen have assigned a buy recommendation to the company. The average twelve-month price objective among brokers that have covered the stock in the last year is $49.94.

A number of equities analysts have commented on ZION shares. Robert W. Baird raised shares of Zions Bancorporation from an “underperform” rating to a “neutral” rating and set a $43.00 price objective for the company in a report on Friday, September 8th. Sanford C. Bernstein reissued a “market perform” rating and set a $51.00 price target on shares of Zions Bancorporation in a report on Saturday, September 16th. Jefferies Group reissued a “buy” rating and set a $49.00 price target on shares of Zions Bancorporation in a report on Friday, September 15th. Keefe, Bruyette & Woods reissued a “hold” rating and set a $48.00 price target on shares of Zions Bancorporation in a report on Tuesday, October 3rd. Finally, Morgan Stanley reissued an “equal weight” rating and set a $49.00 price target (up previously from $48.00) on shares of Zions Bancorporation in a report on Wednesday, October 4th.

In related news, insider Joseph L. Reilly sold 23,271 shares of Zions Bancorporation stock in a transaction dated Wednesday, November 22nd. The shares were sold at an average price of $46.70, for a total transaction of $1,086,755.70. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, General Counsel Thomas E. Laursen sold 1,600 shares of Zions Bancorporation stock in a transaction dated Monday, November 27th. The shares were sold at an average price of $46.55, for a total transaction of $74,480.00. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 43,979 shares of company stock worth $2,057,927. Company insiders own 1.46% of the company’s stock.

A number of institutional investors have recently modified their holdings of ZION. Balyasny Asset Management LLC raised its position in Zions Bancorporation by 705.8% in the second quarter. Balyasny Asset Management LLC now owns 3,186,472 shares of the bank’s stock worth $139,918,000 after acquiring an additional 2,791,044 shares in the last quarter. Ameriprise Financial Inc. raised its position in Zions Bancorporation by 146.8% in the third quarter. Ameriprise Financial Inc. now owns 2,698,958 shares of the bank’s stock worth $127,330,000 after acquiring an additional 1,605,540 shares in the last quarter. Artemis Investment Management LLP raised its position in Zions Bancorporation by 332.1% in the third quarter. Artemis Investment Management LLP now owns 1,751,662 shares of the bank’s stock worth $82,635,000 after acquiring an additional 1,346,240 shares in the last quarter. Cramer Rosenthal Mcglynn LLC raised its position in Zions Bancorporation by 276.0% in the second quarter. Cramer Rosenthal Mcglynn LLC now owns 1,823,738 shares of the bank’s stock worth $80,080,000 after acquiring an additional 1,338,748 shares in the last quarter. Finally, Janus Henderson Group PLC raised its position in Zions Bancorporation by 16,303.3% in the second quarter. Janus Henderson Group PLC now owns 1,231,071 shares of the bank’s stock worth $54,056,000 after acquiring an additional 1,223,566 shares in the last quarter. Hedge funds and other institutional investors own 92.64% of the company’s stock.

Zions Bancorporation (NASDAQ ZION) traded down $0.54 during trading on Friday, reaching $49.22. 2,788,800 shares of the company’s stock were exchanged, compared to its average volume of 2,518,991. The firm has a market capitalization of $9,830.00, a P/E ratio of 18.71, a PEG ratio of 1.92 and a beta of 1.48. The company has a current ratio of 0.80, a quick ratio of 0.80 and a debt-to-equity ratio of 0.05. Zions Bancorporation has a 1 year low of $38.43 and a 1 year high of $52.20.

Zions Bancorporation (NASDAQ:ZION) last released its quarterly earnings data on Monday, October 23rd. The bank reported $0.72 EPS for the quarter, missing analysts’ consensus estimates of $0.73 by ($0.01). The business had revenue of $661.00 million during the quarter, compared to analyst estimates of $666.83 million. Zions Bancorporation had a return on equity of 8.54% and a net margin of 22.70%. During the same period in the prior year, the firm earned $0.57 EPS. research analysts predict that Zions Bancorporation will post 2.8 EPS for the current year.

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, November 22nd. Investors of record on Wednesday, November 15th were paid a dividend of $0.16 per share. This is a boost from Zions Bancorporation’s previous quarterly dividend of $0.12. This represents a $0.64 dividend on an annualized basis and a dividend yield of 1.30%. The ex-dividend date of this dividend was Tuesday, November 14th. Zions Bancorporation’s payout ratio is currently 23.97%.

TRADEMARK VIOLATION NOTICE: “Zions Bancorporation (ZION) Receives Consensus Rating of “Buy” from Brokerages” was reported by The Ledger Gazette and is the property of of The Ledger Gazette. If you are reading this report on another website, it was copied illegally and reposted in violation of US and international copyright legislation. The correct version of this report can be accessed at https://ledgergazette.com/2017/12/15/zions-bancorporation-zion-receives-consensus-rating-of-buy-from-brokerages.html.

Zions Bancorporation Company Profile

Zions Bancorporation is a financial holding company. The Company conducts its banking operations through separately managed and branded segments, including Zions Bank, Amegy Bank, California Bank & Trust, National Bank of Arizona, Nevada State Bank (NSB), Vectra Bank Colorado, The Commerce Bank of Washington (TCBW) and Other.

Analyst Recommendations for Zions Bancorporation (NASDAQ:ZION)

Receive News & Ratings for Zions Bancorporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zions Bancorporation and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply